Home › Funds › Patient Capital Management, LLC › CHYM

Patient Capital Management, LLC position in CHYM

CHIME FINL INC · Financials

Patient Capital Management, LLC reported holding 4,730,900 shares of CHYM (CHIME FINL INC) in its Q3 2026 13F filing — a position valued at US$126.0M, representing 4.26% of its reported portfolio and ranking #9 among its reported holdings. Patient Capital Management, LLC has disclosed CHYM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)4.73M sh
Reported value held$126.03M
Portfolio Weight4.26%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's CHYM position evolved

Patient Capital Management, LLC first disclosed a stake in CHYM in Q4 2025 at 2,035,112 shares (US$51.2M). The position peaked in Q3 2026 at 4,730,900 shares, worth US$126.0M. Across 4 filings, Patient Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,730,900 shares valued at US$126.0M — an increase of 648,411 shares quarter over quarter.. Notable position changes include a 42% increase in Q1 2026 (shares rose 9% over the following quarter), a 42% increase in Q2 2026 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.04M $51.22M New
Q1 2026 2.88M $53.98M Add
Q2 2026 4.08M $83.61M Add
Q3 2026 4.73M $126.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CHYM and 13F data

CHYM (CHIME FINL INC) is a Financials company. 79 other funds we track also report a position in CHYM — the largest reported positions include Galileo (PTC) Ltd (US$959.5M), CROSSLINK CAPITAL INC (US$536.3M), GENERAL ATLANTIC, L.P. (US$435.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CHYM

All CHYM fund holders →

FAQ

How long has Patient Capital Management, LLC held CHYM?

Patient Capital Management, LLC has disclosed CHYM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Patient Capital Management, LLC's current position in CHYM?

As of Q3 2026, Patient Capital Management, LLC holds 4.73M shares of CHYM (CHIME FINL INC), valued at $126.03M, representing 4.26% of its reported portfolio and ranking #9.

Has Patient Capital Management, LLC been buying or selling CHYM?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC increased its position in CHYM. The position peaked in Q3 2026 at 4.73M shares.

Which other funds hold CHYM?

Other major institutional holders of CHYM include Galileo (PTC) Ltd, CROSSLINK CAPITAL INC, GENERAL ATLANTIC, L.P., among 79 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.